Report of Foreign Issuer (6-k)
April 10 2014 - 6:02AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN ISSUER PURSUANT TO
RULE 13a-16 AND 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the Month of
April 2014
File No.
000-54598
Stellar
Biotechnologies Inc.
(Name of Registrant)
332 E. Scott Street, Port Hueneme,
CA 93041
(Address of Principal executive offices)
Indicate by check mark whether the Registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
FORM
20-F
x
FORM
40-F
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this Form 6-K to be signed on its behalf by the undersigned, thereunto duly authorized.
|
Stellar Biotechnologies, Inc.
|
|
|
|
(Registrant)
|
|
|
|
|
|
|
|
Dated:
April
9, 2014
|
By:
|
/s/ “Kathi Niffenegger”
|
|
|
|
Kathi Niffenegger
|
|
|
|
Chief Financial Officer
|
Exhibits:
|
|
99.1
|
Interim Financial Statements for the period ended
February 28, 2014
|
|
|
99.2
|
Management Discussion and Analysis
|
|
|
99.3
|
Certification of CEO
|
|
|
99.4
|
Certification of CFO
|
Stellar Biotechnologies Inc. (NASDAQ:SBOT)
Historical Stock Chart
From Mar 2024 to Apr 2024
Stellar Biotechnologies Inc. (NASDAQ:SBOT)
Historical Stock Chart
From Apr 2023 to Apr 2024
